A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer

NCT00333775 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

736

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Docetaxel
DRUG: Placebo to bevacizumab
DRUG: Bevacizumab

Sponsor

Hoffmann-La Roche